A Prospective Randomised Study of Efficacy, Safety and Costs of Talc Pleurodesis Under Medical Thoracoscopy and Pleurodesis Under Video-assisted Thoracoscopy Surgery for Recurrent Primary Spontaneous Pneumothorax

NCT ID: NCT00767962

Last Updated: 2015-08-24

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 62 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2009-02-28
• Study Completion Date: 2014-12-31

Brief Summary

Treatment of recurrent primary spontaneous pneumothorax remains controversial and many therapeutic options exist. The aim of this study is to compare pleural symphysis by talc poudrage during medical thoracoscopy and surgical management combining pleural abrasion and blebs or bullae resection for treatment of recurrent primary spontaneous pneumothorax.

Detailed Description

Treatment of recurrent primary spontaneous pneumothorax remains controversial and many therapeutic options exist. What is the best technical option : treatment of the lung and the parietal pleura or treatment of the pleura with pleural symphysis ? Talc pleurodesis performed during medical thoracoscopy and resection of blebs or bullae associated with pleural abrasion during surgical thoracoscopy (or video-assisted thoracic surgery) are the most usual methods. These two procedures have never been compared in a prospective trial. The aim of this study is to compare pleural symphysis by talc poudrage during medical thoracoscopy and surgical management combining pleural abrasion and blebs or bullae resection for treatment of recurrent primary spontaneous pneumothorax.

Conditions

Pneumothorax

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

1

talc pleurodesis under medical thoracoscopy

Group Type: OTHER

talc pleurodesis under medical thoracoscopy

Intervention Type: OTHER

talc pleurodesis under medical thoracoscopy for recurrent primary spontaneous pneumothorax

2

pleurodesis under video-assisted thoracoscopy surgery

Group Type: OTHER

pleurodesis under video-assisted thoracoscopy surgery

Intervention Type: OTHER

pleurodesis under video-assisted thoracoscopy surgery for recurrent primary spontaneous pneumothorax

Interventions

talc pleurodesis under medical thoracoscopy

talc pleurodesis under medical thoracoscopy for recurrent primary spontaneous pneumothorax

Intervention Type: OTHER

pleurodesis under video-assisted thoracoscopy surgery

pleurodesis under video-assisted thoracoscopy surgery for recurrent primary spontaneous pneumothorax

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Subjects :both sexes, who the age is included between 18 years and 55 years;
• Presenting a recurrence homolaterale or controlaterale of a primary spontaneous pneumothorax;
• Presenting a bilateral primary spontaneous pneumothorax
• Presenting a failure of a manual inhalation for a primary spontaneous pneumothorax;
• Presenting a persistent superior bullage at 48 am after a thoracic drainage for a spontaneous pneumothorax
• Presenting a persistent superior bullage at 48 am after a thoracic drainage for a primary spontaneous pneumothorax;
• Presenting a persistent superior unsticking at 48 am after a thoracic drainage for a primary spontaneous pneumothorax;
• Presenting a first episode of pneumothorax spontaneous primary with risk factor of recurrence
• The unsticking must be complete or important (superior to 3 cms between the summit of the lung and the summit of the thoracic cavity or superior to 2 cms with regard to the side thoracic wall);
• Benefiting from a national insurance scheme;
• Agreeing to participate in the study, and having read, included and signed the note of information intended in patients.

Exclusion Criteria

• Subjects:Presenting a traumatic pneumothorax; Presenting a pneumothorax iatrogène; Presenting a secondary spontaneous pneumothorax ( underlying pleuro-lung pathology); Presenting bubbles of emphysema of size(cutting) superior to 5 cms; presenting a pneumothorax catamenial;Presenting one of the following concomitant severe pathologies dissuading a general anesthetic or any symphysant gesture(movement): cardiac insufficiency
• Pregnant or breast-feeding Woman;
• presenting neurological disorders or psychiatric forbidding the understanding of the essay;
• Who the follow-up is impossible;
• Deprived of freedom following a court or administrative order;
• Not having signed the enlightened assent.

• Minimum Eligible Age: 15 Years
• Maximum Eligible Age: 55 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Assistance Publique Hopitaux De Marseille

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Anne FRATICELLI, MD

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique des Hopitaux de Marseille

Locations

Service d'Oncologie Thoracique- Hôpital Sainte Marguerite

Marseille, , France

Countries

France

Other Identifiers

2007-A00342-51

Identifier Type: -

Identifier Source: org_study_id